Dermal Fillers Market to Reach US$ 4.04 Bn by the End of 2021: Future Market Insights

Market

Diverse applications of dermal fillers in helping to improve an individual’s appeatance have been sustaining growth of the market. According to FMI, dermal fillers market is projected to exhibit 2.9% CAGR between 2021 and 2031

Future Market Insights, Dubai: Growing inclination towards non-invasive procedures and increasing efficiency of dermal fillers have been driving the dermal fillers market. Future Market Insights (FMI) in a new study has projected the market to reach US$ 4.04 Bn by the end of 2021. The application of dermal fillers ranges from better aesthetic outcomes to the treatment of forehead augmentation.

The use of dermal fillers is not restricted to facial skin procedures, it also includes various derma aesthetic procedure treatment. Moreover, an increase in the number of non-invasive aesthetic surgeries and an increasing number of aesthetic surgeons are expected to be important factors for surging the demand for dermal fillers.

According to the Plastic Surgery Statistics Report, in 2019, there were around 13,618,735 non-surgical procedures performed by plastic surgeons worldwide.

Additionally, increasing awareness concerning the dermal fillers in emerging countries, the emergence of new products and new indications are enabling growth. Besides this, the rising aging population is one of the major factors that is rapidly fuelling the demand for dermal fillers. The rising demand for anti-ageing treatment to effectively diminish the signs of ageing and facial treatment will keep the demand for dermal fillers high.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5699

FMI has projected absorbable dermal fillers to remain most preferred. It is expected to account for over 99% of dermal fillers sold through 2031.

Key Takeaways of Dermal Fillers Market Study

  • The global dermal fillers market will continue expanding at a steady pace. FMI has projected the market to exhibit 2.8% Y-o-Y growth in 2021
  • The U.S. is one of the key markets for dermal fillers, accounting for over 89% of North America market in 2021
  • Demand for dermal fillers is expected to remain significantly high in the U.K. FMI has projected it to exhibit over 5% Y-o-Y growth in 2021
  • Germany and France are other lucrative markets for dermal fillers in Europe
  • Dermal fillers sales in Japan are expected to be considerably high. South Korea too will continue exhibiting rising demand for dermal fillers

“Achieving approvals from international organizations and product launches are among key strategies adopted by the market players. They are primarily focusing on catering to the demand for non-invasive cosmetic procedures among patients,” says the FMI Analyst

 

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/ask-question/rep-gb-5699

Who is Winning?

The regulatory approval for new products is one of the key factor responsible for enormous competition among market players globally. Some of the leading market players have been focusing on product launches. Besides this mergers & acquisitions and collaboration remain the key trends among market players intending to expand their footprint globally.

For instance, AbbVie Inc., acquired Allergan Aesthetics, the onset of the completion of its acquisition of Irish-domiciled pharmaceutical company in January 2020. Allergan Aesthetics would operate as a new global dedicated business with its research & development function including aesthetic products, botox Cosmetic, the Juvederm collection of dermal fillers, and Coolsculpting body contouring.

Also, Revance Therapeutics signed an exclusive U.S. distribution agreement in January 2020 with Teoxane SA for its innovative Resilient Hyaluronic Acid products like RHA2, RHA3, and RHA4. Hence this agreement would expand the Teoxane’s aesthetic products sales.

In Oct 2020, Sinclair Pharmaceuticals Ltds. signed a strategic distributorship agreement with Tamer Group KSA, intending to expand its aesthetic profile sales footprint in the Middle East and Africa with its exclusive distributor in Saudi Arabia.

More Valuable Insights on Dermal Fillers Market

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global dermal fillers market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readerThe study provides compelling insights on dermal fillers market on basis of product type (absorbable, non-absorbable), by ingredient (hyaluronic acid, poly-L-lactic acid, calcium hydroxylapatite, polymethyl methacrylate, and collagen), and distribution channel (retail pharmacies and drug stores, clinic and hospital pharmacies, online pharmacies), across seven major regions.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-5699

Explore FMI’s Extensive Coverage on Healthcare Domain

Sodium Lactate Market: The overall sodium lactate sales are expected to reach US$ 368.3 Mn by 2031, growing at a CAGR of 8.8% for 2021 – 2031.

Advanced Wound Management Market: Rising Cases of Chronic Ulcers to Spur Sales in Advanced Wound Management Market

Herbal Medicinal Products Market: Ayurvedic Medicines to Account for Over Half of Herbal Medicinal Products Sales through 2031.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

Contact:

Future Market Insights,

1602-6 Jumeirah Bay X2 Tower,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Website: https://www.futuremarketinsights.com/

Report: https://www.futuremarketinsights.com/reports/dermal-fillers-market

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”